Cagrilintide (CGL10) is a long-acting acylated amylin analogue research peptide used for research on amylin receptors, metabolic regulation, and peptide pharmacological mechanisms.
Cagrilintide (CGL10) is a long-acting modified peptide based on optimized design of human amylin structure. Composed of 32 amino acids, its research value is enhanced through fatty acid chain modification. This molecule belongs to the amylin analogue family and can act on the amylin receptor (AMYR) and related receptor pathways, enabling the exploration of peptide structure, receptor interactions, and metabolic regulatory mechanisms. CGL10 is provided as a white to off-white lyophilized powder, and its quality was assessed by HPLC purity analysis and LC-MS identification.
Cagrilintide (CGL10) is primarily used in metabolic biology, endocrinology research, and peptide pharmacology. Researchers utilize this compound to study amylin receptor (AMYR) signaling, calmodulin receptor mechanisms, energy balance regulation, food intake regulation mechanisms, and the optimization of long-acting peptide structures. This compound can serve as a research tool to explore the mechanisms of action of amylin analogues in complex metabolic networks.
Freeze-dried powder state:
Recommended:
Long-term storage:
-20℃
Requirements:
✅ Protect from light
✅ Dry
✅ Store in an airtight container
Avoid:
High temperatures
Repeated freeze-thaw cycles
Prolonged exposure to air
Retatrutide (RT10) is a synthetic peptide research compound designed as a triple...
Retatrutide (RT20) is a novel synthetic modified peptide, with the research code...
Retatrutide RT30 is a 30mg research-grade peptide product of Retatrutide (LY3437...
Contact our team for volume discounts and custom peptide services
Weitai Bio is a national high-tech enterprise specializing in the research, development, production, and sales of peptide drugs. It is also a leading global supplier of high-quality peptides, consistently focusing on peptide drugs and small nucleic acid fields.